Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population

por Xu, Hong-Li, Cheng, Jia-Rong, Zhang, Wei, Wang, Jing, Yu, Herbert, Ni, Quan-Xing, Risch, Harvey A., Gao, Yu-Tang
Publicado 2014

Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis via suppression of sirtuin 3 in pancreatic cancer

por Xu, Wen-Yan, Hu, Qiang-Sheng, Qin, Yi, Zhang, Bo, Liu, Wen-Sheng, Ni, Quan-Xing, Xu, Jin, Yu, Xian-Jun
Publicado 2018

Active surveillance in metastatic pancreatic neuroendocrine tumors: A 20-year single-institutional experience

por Gao, He-Li, Wang, Wen-Quan, Xu, Hua-Xiang, Wu, Chun-Tao, Li, Hao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Publicado 2020

Urinary Prostaglandin E(2) Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai

por Zhao, Jing, Wang, Jing, Du, Jinfeng, Xu, Hongli, Zhang, Wei, Ni, Quan-Xing, Yu, Herbert, Risch, Harvey A., Gao, Yu-Tang, Gao, Ying
Publicado 2015

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine

por Liang, Chen, Yu, Xian-Jun, Guo, Xiao-Zhong, Sun, Meng-Hong, Wang, Zhen, Song, Yao, Ni, Quan-Xing, Li, Hong-Yu, Mukaida, Naofumi, Li, Ying-Yi
Publicado 2015

SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer

por Li, Hao, Zhang, Shi-Rong, Xu, Hua-Xiang, Wang, Wen-Quan, Li, Shuo, Li, Tian-Jiao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang, Wu, Chun-Tao
Publicado 2019

RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling

por Qi, Zi-Hao, Xu, Hua-Xiang, Zhang, Shi-Rong, Xu, Jin-Zhi, Li, Shuo, Gao, He-Li, Jin, Wei, Wang, Wen-Quan, Wu, Chun-Tao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Publicado 2018

The Significance of Liquid Biopsy in Pancreatic Cancer

por Qi, Zi-Hao, Xu, Hua-Xiang, Zhang, Shi-Rong, Xu, Jin-Zhi, Li, Shuo, Gao, He-Li, Jin, Wei, Wang, Wen-Quan, Wu, Chun-Tao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Publicado 2018

The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

por Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Sun, Hui-Chuan, Wu, Chun-Tao, Zhu, Xiao-Dong, Zhang, Wei, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Tang, Zhao-You, Yu, Xian-Jun
Publicado 2014

Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer

por Xu, Shuai-Shuai, Li, Shuo, Xu, Hua-Xiang, Li, Hao, Wu, Chun-Tao, Wang, Wen-Quan, Gao, He-Li, Jiang, Wang, Zhang, Wu-Hu, Li, Tian-Jiao, Ni, Quan-Xing, Liu, Liang, Yu, Xian-Jun
Publicado 2020

Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

por Xiang, Jin-Feng, Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Wu, Chun-Tao, Yang, Jing-Xuan, Qi, Zi-Hao, Wang, Ya-Qi, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Li, Min, Yu, Xian-Jun
Publicado 2016

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

por Xiang, Jin-Feng, Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Wu, Chun-Tao, Yang, Jing-Xuan, Qi, Zi-Hao, Wang, Ya-Qi, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Li, Min, Yu, Xian-Jun
Publicado 2016

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

por Liu, Liang, Xu, Hua-Xiang, Wang, Wen-Quan, Wu, Chun-Tao, Xiang, Jin-Feng, Liu, Chen, Long, Jiang, Xu, Jin, Fu, De-Liang, Ni, Quan-Xing, Houchen, Courtney W., Postier, Russell G., Li, Min, Yu, Xian-Jun
Publicado 2016